A detailed history of Carret Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Carret Asset Management, LLC holds 50,759 shares of ABBV stock, worth $8.91 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
50,759
Previous 51,770 1.95%
Holding current value
$8.91 Million
Previous $8.88 Million 12.88%
% of portfolio
1.12%
Previous 1.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$163.84 - $199.33 $165,642 - $201,522
-1,011 Reduced 1.95%
50,759 $10 Million
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $28,636 - $33,440
-185 Reduced 0.36%
51,770 $8.88 Million
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $62,489 - $71,201
-391 Reduced 0.75%
51,955 $9.46 Million
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $17,888 - $20,146
-130 Reduced 0.25%
52,346 $8.11 Million
Q3 2023

Oct 12, 2023

SELL
$133.59 - $154.65 $96,184 - $111,348
-720 Reduced 1.35%
52,476 $7.82 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $1.04 Million - $1.29 Million
-7,822 Reduced 12.82%
53,196 $7.17 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $615,315 - $708,627
-4,255 Reduced 6.52%
61,018 $9.72 Million
Q4 2022

Jan 10, 2023

SELL
$138.31 - $165.87 $55,185 - $66,182
-399 Reduced 0.61%
65,273 $10.5 Million
Q3 2022

Oct 11, 2022

SELL
$134.21 - $153.93 $130,854 - $150,081
-975 Reduced 1.46%
65,672 $8.81 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $191,154 - $243,019
-1,389 Reduced 2.04%
66,647 $10.2 Million
Q1 2022

Apr 13, 2022

SELL
$131.98 - $163.75 $10,294 - $12,772
-78 Reduced 0.11%
68,036 $11 Million
Q4 2021

Jan 10, 2022

BUY
$107.43 - $135.93 $15,040 - $19,030
140 Added 0.21%
68,114 $9.22 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $31,813 - $36,113
-299 Reduced 0.44%
67,974 $7.33 Million
Q2 2021

Jul 14, 2021

SELL
$105.21 - $117.21 $24,198 - $26,958
-230 Reduced 0.34%
68,273 $7.69 Million
Q1 2021

Jul 14, 2021

BUY
$102.3 - $112.62 $10,230 - $11,262
100 Added 0.15%
68,503 $7.41 Million
Q4 2020

Mar 16, 2021

SELL
$80.49 - $108.67 $18,110 - $24,450
-225 Reduced 0.33%
68,403 $7.33 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $225,256 - $264,376
-2,622 Reduced 3.68%
68,628 $6.01 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $216,881 - $290,220
2,956 Added 4.33%
71,250 $7 Million
Q1 2020

May 18, 2020

SELL
$64.5 - $97.79 $73,659 - $111,676
-1,142 Reduced 1.64%
68,294 $5.2 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $106,824 - $133,660
1,481 Added 2.18%
69,436 $6.15 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $6,612 - $7,950
-105 Reduced 0.15%
67,955 $5.15 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $16,425 - $20,995
250 Added 0.37%
68,060 $4.95 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $50,141 - $59,013
-650 Reduced 0.95%
67,810 $5.47 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $21,408 - $26,402
275 Added 0.4%
68,460 $6.31 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $76,996 - $85,595
-866 Reduced 1.25%
68,185 $6.45 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $61,050 - $72,236
-680 Reduced 0.98%
69,051 $6.4 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $302,068 - $404,498
-3,283 Reduced 4.5%
69,731 $6.6 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $29,107 - $31,918
-325 Reduced 0.44%
73,014 $7.06 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $32,480 - $41,487
465 Added 0.64%
73,339 $6.52 Million
Q2 2017

Aug 15, 2017

BUY
N/A
72,874
72,874 $5.28 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Carret Asset Management, LLC Portfolio

Follow Carret Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.